280,16 €
311,29 €
-10% with code: EXTRA
Advances in Precision Medicine Oncology
Advances in Precision Medicine Oncology
280,16
311,29 €
  • We will send in 10–14 business days.
Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAE…
  • Publisher:
  • ISBN-10: 183968867X
  • ISBN-13: 9781839688676
  • Format: 17 x 24.4 x 1.6 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Advances in Precision Medicine Oncology (e-book) (used book) | bookbook.eu

Reviews

Description

Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects.

EXTRA 10 % discount with code: EXTRA

280,16
311,29 €
We will send in 10–14 business days.

The promotion ends in 16d.09:18:14

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 3,11 Book Euros!?
  • Publisher:
  • ISBN-10: 183968867X
  • ISBN-13: 9781839688676
  • Format: 17 x 24.4 x 1.6 cm, hardcover
  • Language: English English

Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)